GlobeNewswire

Sangamo Therapeutics Selects Successful Bidders Following Competitive Asset Auction for $163.55 Million in Cash Consideration at Closing and Up to $100 Million in Potential Milestones
12/08/2026
PTC Therapeutics to purchase Fabry disease program, isaralgagene civaparvovec Lilly to purchase capsid delivery, zinc finger and modular integrase (MINT) platforms and prion disease program Proposed sales subject to [...]
Hyperion DeFi Reports 2Q 2026 Financial Results with Another Record Quarterly Net Income and Strong Operating Momentum
12/08/2026
Company Reports Record $31.0M Net Income and $53.7M Adjusted EBITDA ( 8 ) Announcing New HAUS Agreement with Entropy, an Upcoming HIP-3 Deployer 1 Million HYPE Tokens Redeployed to Support HIP-3 & HIP-4 Markets [...]
Earth Science Tech, Inc. (ETST) Expands National Footprint with Strategic Acquisition of California Compounding Pharmacy, Meduvo LLC
12/08/2026
MIAMI, Aug. 12, 2026 (GLOBE NEWSWIRE) -- Earth Science Tech, Inc. (OTC: ETST) (“ETST” or the “Company”), a strategic holding company focused on a diversified portfolio, today announced the acquisition of Meduvo LLC, a [...]
Rampart retire son recours contre la décision d’invalidation de l’USPTO
12/08/2026
ST. PAUL, Minnesota, 12 août 2026 (GLOBE NEWSWIRE) -- Egg Medical a annoncé que Rampart IC, LLC (« Rampart ») avait retiré son recours contre la décision de réexamen de l’USPTO, selon laquelle les revendications du [...]
Dr. Wallace Brucker Offers Galleri Multi-Cancer Early Detection Testing in Las Vegas as Part of Proactive Longevity Care
12/08/2026
Las Vegas, Nevada, Aug. 12, 2026 (GLOBE NEWSWIRE) -- LV Longevity Lab integrates an advanced blood test capable of screening for a signal shared by more than 50 types of cancer into its proactive, prevention-first [...]
Interra Health Named on the 2026 Inc. 5000 List of America’s Fastest-Growing Private Companies
12/08/2026
Company Recognized for 107 Percent Three-Year Revenue Growth, Earning a Place Among the Nation’s Most Successful Independent Businesses BOSTON, Aug. 12, 2026 (GLOBE NEWSWIRE) -- Interra Health , which delivers the first [...]
New review prioritizes maternal mental health during pregnancy
12/08/2026
Children’s National-led study highlights the benefits of treating major depression during pregnancy and the importance of balanced decision-making around SSRI use Washington, DC, Aug. 12, 2026 (GLOBE NEWSWIRE) -- [...]
Robotic Technology at Medicana: CyberKnife Tracks Tumors in Real Time and Adjusts Radiation as Patients Breathe
12/08/2026
Medicana Health Group radiation oncologist Prof. Dr. Kaan Oysul says real-time motion tracking helps keep radiation focused on moving tumors while limiting exposure to nearby critical organs Photo: Prof. Dr. Kaan Toysul [...]
Regenix Labs Announces Educational Guide on Cortisol, Stress Management, and Healthy Adrenal Function
12/08/2026
New educational guide explores cortisol, stress management, and nutritional ingredients that support overall wellness and healthy adrenal function. Regenix Labs logo. NEWARK, Del., Aug. 12, 2026 (GLOBE NEWSWIRE) -- [...]
Applied Biologics Launches National Health System Partnership Initiative
12/08/2026
Company expands strategic engagement with health systems, integrated delivery networks, and group purchasing organizations to support physicians and patients nationwide SCOTTSDALE, Ariz., Aug. 12, 2026 (GLOBE NEWSWIRE [...]
Tris Pharma Expands Support for People Living with ADHD Through New Partnerships with Calm Health and ADHD Central
12/08/2026
Initiatives Provide New DYANAVEL® XR Patients With Digital Wellness Resources and Practical Organization Tools Designed to Support ADHD Care Beyond Medication MONMOUTH JUNCTION, N.J., Aug. 12, 2026 (GLOBE NEWSWIRE) -- [...]
Dyadic Announces Second Quarter 2026 Financial Results Accelerating Commercialization Momentum Across Key Business Areas
12/08/2026
Dyadic to host earnings call on August 12 at 5:00 pm ET JUPITER, Fla., Aug. 12, 2026 (GLOBE NEWSWIRE) -- Dyadic International, Inc. (“Dyadic”, “we”, “us”, “our”, or the “Company”) (NASDAQ: DYAI), d/b/a Dyadic Applied [...]
Propanc Biopharma Highlights Differentiated Proenzyme Therapy PRP as a Potential Therapy of Choice Against RAS-Driven Cancers
12/08/2026
Contrasting Science with Revolution Medicines and Erasca MELBOURNE, Australia, Aug. 12, 2026 (GLOBE NEWSWIRE) -- Propanc Biopharma, Inc. (Nasdaq: PPCB) (“Propanc” or the “Company”), a biopharmaceutical company focused [...]
Aprea Therapeutics Announces Second Quarter 2026 Financial Results
12/08/2026
Enrollment in the ongoing Phase 1 dose escalation ACESOT-1051 trial of oral WEE1 inhibitor APR-1051 is accelerating as dose escalation advances Aprea plans to advance APR-1051 in uterine serous carcinoma (USC), and [...]
Avaí Bio and Austrianova Announce Research Collaboration with San Raffaele Hospital to Advance Encapsulated Cell Therapy for Diabetes
12/08/2026
Agreement combines Austrianova’s Cell-in-a-Box® technology with San Raffaele Hospital’s stem cell-derived beta cell expertise through a research collaboration with Avaí Bio and Austrianova’s JV Company, Insulinova, [...]
SciSparc’s Subsidiary NeuroThera Labs Granted Japanese Patent for its Proprietary, Innovative Therapeutic Combination
12/08/2026
TEL AVIV, Israel, Aug. 12, 2026 (GLOBE NEWSWIRE) -- SciSparc Ltd. (Nasdaq: SPRC) (“Company” or “SciSparc”), today announced that NeuroThera Labs Inc. (TSXV: NTLX) ("NeuroThera"), a clinical-stage pharmaceutical company [...]
Autonomix Medical Completes Good Laboratory Practice (GLP) Preclinical Study, Marking Key Step Toward FDA Submission
12/08/2026
Final histology and laboratory analyses support the study’s safety and performance objectives THE WOODLANDS, TX, Aug. 12, 2026 (GLOBE NEWSWIRE) -- Autonomix Medical, Inc. (NASDAQ: AMIX) (“Autonomix” or the “Company”), a [...]
SCIENTURE Announces Commercial Launch and Fulfillment of Initial Purchase Orders of REZENOPY™, the Highest Dose FDA-Approved Naloxone Nasal Spray
12/08/2026
Commercial launch supported by a dedicated national sales force, payer and institutional access, and multi-channel marketing campaign supporting adoption of REZENOPY ™ Targeting continued commercial execution through [...]
Avalyn Reports Second Quarter 2026 Financial Results and Recent Business Highlights
12/08/2026
Completed enrollment of MIST global Phase 2b trial of AP01 with 398 patients; topline data expected in the second half of 2027 Two abstracts accepted for presentation at the European Respiratory Society (ERS) Congress, [...]

Pages

Other news

Test 2

Lorem ipsum

Test 1

Lorem upsum